Cearvol Diamond X1 vs Signia Pure C&G IX

The Cearvol Diamond X1 is a budget-priced OTC hearing aid available for $199, earning a B grade with a SoundScore of 3.7/5 in our lab testing. This visible-in-ear style device ranks #30 among 65 OTC hearing aids tested, placing it in the top 45% of its category. The Diamond X1 delivers a mixed performance profile with one notable strength: music streaming. With a score of 4.1/5, it performs 2.18 points above the category average—a substantial margin that makes it appealing for users who value audio entertainment through their hearing aids. Feedback handling is excellent at 4.5/5, providing stable performance during typical daily movements. Both iPhone and Android streaming are supported with rechargeable batteries for convenience. Speech performance presents a more modest picture. Speech in quiet scores 2.8/5, which is above the category average but only mixed in absolute terms. Speech in noise measures 1.7/5—above the category average of 1.48/5, though still low overall. Own-voice comfort is a weakness at 1.7/5, falling 0.81 points below the category average, which may cause your own voice to sound unnatural or boomy. The Diamond X1 is best suited for budget-conscious consumers who prioritize music and media streaming over maximum speech clarity. Those seeking stronger speech performance in challenging listening environments may want to consider higher-scoring alternatives in this price range, such as the Elehear Beyond or Apple AirPods Pro 2.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.